Department: DEPARTMENT OF HEALTH AND HUMAN SERVICES
Pages: 1
[FR Doc 04-1843] 1. Proposed Data Collections Submitted for Public Comment and Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a
Published: 2004-01-29 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Centers for Disease Control and Prevention
[FR Doc 04-1906] 2. Public Notice
This is a request for information only. It is not a request for proposal and does not commit the government to issue a solicitation, make an award, or pay any costs associated with responding to this announcement. All submitted information shall remain with the government and will not be returned.
The Centers for Disease Control and Prevention
Published: 2004-01-29 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Centers for Disease Control and Prevention
[FR Doc 04-1905] 3. Statement of Organization, Functions, and Delegations of Authority
Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 6777276, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 68 FR 6245662459, dated November 4, 2003) is amended to
Published: 2004-01-29 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Centers for Disease Control and Prevention
[FR Doc 04-1839] 4. Agency Information Collection Activities; Proposed Collection; Comment
The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each
Published: 2004-01-29 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 04-1840] 5. Determination of Regulatory Review Period for Purposes of Patent Extension;
The Food and Drug Administration (FDA) has determined the regulatory review period for FROVA and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of two applications to the Director of Patents and Trademarks, Department of Commerce, for the extension of two patents that
Published: 2004-01-29 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 04-1841] 6. Determination of Regulatory Review Period for Purposes of Patent Extension;
The Food and Drug Administration (FDA) has determined the regulatory review period for REMODULIN and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of Patents and Trademarks, Department of Commerce, for the extension of a patent that
Published: 2004-01-29 DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration
[FR Doc 04-1887] 7. Record of Decision--Construction and Operation of an Integrated Research
The National Institute of Allergy and Infectious Diseases (NIAID), a component of NIH, will be the occupant of the facility, which will contain Intramural NIAID biosafety level 2, 3, and 4 laboratory and animal research facilities for conducting biodefense and emerging infectious disease research. NIAID's biodefense mission is different but
Published: 2004-01-29 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health
Pages: 1